Winship Cancer Institute’s Carlos Moreno has a sharply written commentary on Reuters, whipping Big Pharma for footdragging on cancer drug discovery for patent/IP-related reasons. Check it out.
More of Moreno’s writings:
Commentary on federal budget deal making, on Talking Points Memo (once a one man blog, now a political news hub)
About the author
